(BPCA) Information Coordinating Center was funded under contract HHSN275201700002C (PI
(BPCA) Data Coordinating Center was funded under contract HHSN275201700002C (PI, Ravinder Anand). Y.S.S.W. was supported through a University of North Carolina (UNC)/Nuventra Pharmacokinetics/Pharmacodynamics Fellowship. M.C.-W. received assistance for analysis from the RORγ MedChemExpress National Institutes of Wellness (grants 1R01-HD076676-01A1 and 1K24-AI143971),July 2021 Volume 65 Situation 7 e02149-20 aac.asmWu et al.Antimicrobial Agents and Chemotherapythe National Institute of Allergy and Infectious Diseases (grants HHSN272201500006I and HHSN272201300017I), the National Institute of Child Wellness and Human Improvement (NICHD) (grant HHSN275201000003I), the U.S. Meals and Drug Administration (grant 5U18FD006298), and business for drug improvement in adults and kids. C.P.H. received salary support for investigation from NICHD (grants 1K23HD090239 and R13HD102136), the National Heart Lung and Blood Institute (NHLBI) (grant R61/R33HL147833), as well as the U.S. Meals and Drug Administration (grants 1R01-FD006099 [PI, Matthew Laughon] and 5U18-FD006298 [PI, Daniel K. Benjamin, Jr.]), and in the U.S. government for his perform in pediatric clinical pharmacology (contract HHSN275201800003I [PI, Daniel K. Benjamin, Jr.] under the top Pharmaceuticals for Young children Act), in the nonprofit Burroughs Wellcome Fund, and from other sponsors for drug development in adults and children (dcri/about-us/ conflict-of-interest/). J.G.G. received study help from the National Institute of General Medical Sciences (NIGMS)-funded T32 plan (award 5T32GM122741), too because the American Foundation for Pharmaceutical Education (AFPE). D.G. received study support from the NICHD (grants K23HD083465 and R01HD096435). The content material is solely the duty from the authors and does not necessarily represent the official views of your National Institutes of Well being. Y.S.S.W. and D.G. wrote the manuscript; Y.S.S.W. and D.G. developed the analysis; Y.S.S.W., M.C.-W., C.P.H., J.G.G., J.A., M.C., and D.G. performed the study; Y.S.S.W. and J.G.G. analyzed the information. PTN Steering Committee Members include Daniel K. Benjamin, Jr., Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, and Rose Beci, Duke Clinical Research Institute, Durham, NC; Chi Dang Hornik, Duke University Medical Center, Durham, NC; Gregory L. Kearns, Texas Christian University and UNTHSC School of Medicine, Fort Worth, TX; Matthew Laughon, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ian M. Paul, Penn State College of Medicine, Hershey, PA; Janice Sullivan, University of PD-1/PD-L1 Modulator site Louisville, Louisville, KY; Kelly Wade, Children’s Hospital of Philadelphia, Philadelphia, PA; and Paula Delmore, Wichita Healthcare Investigation and Education Foundation, Wichita, KS. The Eunice Kennedy Shriver National Institute of Youngster Well being and Human Improvement (NICHD) group members include Perdita Taylor-Zapata and June Lee. The Emmes Company, LLC (Data Coordinating Center), team members contain Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, and Lawrence Taylor. The PTN Publications Committee is chaired by Thomas Green, Ann Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL. The Pediatric Trials Network trimethoprim-sulfamethoxazole POPS study group, principal investigators (PIs), and study coordinators (SCs) are as follows: in the Duke Clinical Study Institute, Tammy Day (clinical investigation associate [CRA]); at the Universitde Montr l, Julie Autmizguine (PI); at the University of North Carolina at Chapel Hill, Matthew.
